Quote · Schwab Network
The Future of Healthcare: Will AI Detect Diseases Before Stage 1?
Where this was said
AI in Healthcare: Real-World Applications Already Taking Shape
At 3:38 · chapter starts 2:55
After the geopolitical detour, the conversation turns to what's actually happening on the ground in AI healthcare — and Armani gets specific. He names Open Evidence, an AI platform with a subscription model that connects doctors globally for peer consultation, and Tri Discovery, which is applying AI to drug discovery. [1] — Sidney Armani "Open Evidence is building a subscription platform that lets doctors consult with peers across the globe, powered by AI. It's an early examp…" 02:55 Neither is publicly traded yet, which is part of his point: the most interesting AI healthcare plays are still private, and the opportunity for investors is in identifying them early. His framing for retail investors is practical — look at the companies you interact with as a patient, not just the infrastructure names everyone already knows. It's a subtle but useful reorientation of where to focus attention.
Open Evidence is building a subscription platform that lets doctors consult with peers across the globe, powered by AI. It's an early example of how AI shifts from buzzword to measurable clinical tool.
Open Evidence offers a subscription platform allowing doctors worldwide to consult with each other, powered by AI.
Ransomware groups have become so sophisticated they now offer customer service to their victims. Armani highlights this as a sign of how organized and dangerous the cybercrime ecosystem has become — and why AI-powered defense is urgent.
AI will dramatically improve medical diagnostics, but it won't replace doctors. The human elements of medicine — holding a patient's hand, delivering comfort, exercising clinical judgment — remain beyond what any algorithm can provide.
